Search results

Breast cancer is a global public health dilemma and the most prevalent cancer in the world. Effective treatment plans improve patient survival rates and well-being. The five-year survival rate is often used to develop treatment selection and survival prediction models. However, unlike other types of cancer, breast cancer patients can have long survival rates. Therefore, the authors propose a novel two-level framework to provide clinical decision support for treatment selection contingent on survival prediction.

The first level classifies patients into different survival periods using machine learning algorithms. The second level has two models with different survival rates (five-year and ten-year). Thus, based on the classification results of the first level, the authors employed Bayesian networks (BNs) to infer the effect of treatment on survival in the second level.

The authors validated the proposed approach with electronic health record data from the TriNetX Research Network. For the first level, the authors obtained 85% accuracy in survival classification. For the second level, the authors found that the topology of BNs using Causal Minimum Message Length had the highest accuracy and area under the ROC curve for both models. Notably, treatment selection substantially impacted survival rates, implying the two-level approach better aided clinical decision support on treatment selection.

The authors have developed a reference tool for medical practitioners that supports treatment decisions and patient education to identify patient treatment preferences and to enhance patient healthcare.

In time and accurate detection of cancer can save the life of the person affected. According to the World Health Organization (WHO), breast cancer occupies the most frequent incidence among all the cancers whereas breast cancer takes fifth place in the case of mortality numbers. Out of many image processing techniques, certain works have focused on convolutional neural networks (CNNs) for processing these images. However, deep learning models are to be explored well.

In this work, multivariate statistics-based kernel principal component analysis (KPCA) is used for essential features. KPCA is simultaneously helpful for denoising the data. These features are processed through a heterogeneous ensemble model that consists of three base models. The base models comprise recurrent neural network (RNN), long short-term memory (LSTM) and gated recurrent unit (GRU). The outcomes of these base learners are fed to fuzzy adaptive resonance theory mapping (ARTMAP) model for decision making as the nodes are added to the F_2ˆa layer if the winning criteria are fulfilled that makes the ARTMAP model more robust.

The proposed model is verified using breast histopathology image dataset publicly available at Kaggle. The model provides 99.36% training accuracy and 98.72% validation accuracy. The proposed model utilizes data processing in all aspects, i.e. image denoising to reduce the data redundancy, training by ensemble learning to provide higher results than that of single models. The final classification by a fuzzy ARTMAP model that controls the number of nodes depending upon the performance makes robust accurate classification.

Research in the field of medical applications is an ongoing method. More advanced algorithms are being developed for better classification. Still, the scope is there to design the models in terms of better performance, practicability and cost efficiency in the future. Also, the ensemble models may be chosen with different combinations and characteristics. Only signal instead of images may be verified for this proposed model. Experimental analysis shows the improved performance of the proposed model. This method needs to be verified using practical models. Also, the practical implementation will be carried out for its real-time performance and cost efficiency.

The proposed model is utilized for denoising and to reduce the data redundancy so that the feature selection is done using KPCA. Training and classification are performed using heterogeneous ensemble model designed using RNN, LSTM and GRU as base classifiers to provide higher results than that of single models. Use of adaptive fuzzy mapping model makes the final classification accurate. The effectiveness of combining these methods to a single model is analyzed in this work.

Value-based healthcare suggested using patient-reported information to complement the information available in the medical records and administrative healthcare data to provide insights into patients' perceptions of satisfaction, experience and self-reported outcomes. However, little attention has been devoted to questions about factors fostering the use of patient-reported information to create value at the system level.

Action research design is carried out to elicit possible triggers using the case of patient-reported experience and outcome data for breast cancer women along their clinical pathway in the clinical breast network of Tuscany (Italy).

The case shows that communication and engagement of multi-stakeholder representation are needed for making information actionable in a multi-level, multispecialty care pathway organized in a clinical network; moreover, political and managerial support from higher level governance is a stimulus for legitimizing the use for quality improvement. At the organizational level, an external facilitator disclosing and discussing real-world uses of collected data is a trigger to link measures to action. Also, clinical champion(s) and clear goals are key success factors. Nonetheless, resource munificent and dedicated information support tools together with education and learning routines are enabling factors.

Current literature focuses on key factors that impact performance information use often considering unidimensional performance and internal sources of information. The use of patient/user-reported information is not yet well-studied especially in supporting quality improvement in multi-stakeholder governance. The work appears relevant for the implications it carries, especially for policymakers and public sector managers when confronting the gap in patient-reported measures for quality improvement.

Breast-cancer-related lymphedema (BCRL) is a negative condition that affects biopsychosocial aspects of patients treated with breast cancer. Yoga has been reported as one of the complementary and alternative approaches used by patients diagnosed with BCRL. The aim of this systematic review was to explore the effectiveness of yoga on BCRL.

A systematic literature was performed by searching existing papers from the electronic scientific databases. Five papers were exclusively examined. Four studies were conducted in women with BCRL, and one study was conducted with women at risk for BCRL.

Four types of yoga were evaluated in relationship with BCRL, namely: the Satyananda Yoga tradition, the modified Hatha yoga, the aerobic yoga training and the Ashtanga-based yoga practices. Four of five included studies reported that decrease in arm volume was not reported for all yoga-type interventions. One study showed no significant evidence that yoga was associated with limb volume change in women at risk of BCRL. Similarly, three studies reported that the change-of-arm-volume measures were not significantly different between the yoga and the control groups or in the same group before and after the yoga program. One quasi-experimental study reported arm volume significantly decreased after attending the yoga program.

This review reported the importance of being aware that yoga is not shown to be an effective strategy for managing or preventing BCRL. However, quality of research methodology, small sample sizes and the limited number of related studies should be acknowledged. Until more rigorous studies are performed, yoga may continue to be used as a complement to traditional therapy under the supervision of certified trainers.

Breast cancer is an important medical disorder, which is not a single disease but a cluster more than 200 different serious medical complications.

The new artificial bee colony (ABC) implementation has been applied to probabilistic neural network (PNN) for training and testing purpose to classify the breast cancer data set.

The new ABC algorithm along with PNN has been successfully applied to breast cancers data set for prediction purpose with minimum iteration consuming.

The new implementation of ABC along PNN can be easily applied to times series problems for accurate prediction or classification.

Computer vision for automated analysis of cells and tissues usually include extracting features from images before analyzing such features via various machine learning and machine vision algorithms. The purpose of this work is to explore and demonstrate the ability of a Convolutional Neural Network (CNN) to classify cells pictured via brightfield microscopy without the need of any feature extraction, using a minimum of images, improving work-flows that involve cancer cell identification.

The methodology involved a quantitative measure of the performance of a Convolutional Neural Network in distinguishing between two cancer lines. In their approach, they trained, validated and tested their 6-layer CNN on 1,241 images of MDA-MB-468 and MCF7 breast cancer cell line in an end-to-end fashion, allowing the system to distinguish between the two different cancer cell types.

They obtained a 99% accuracy, providing a foundation for more comprehensive systems.

Value can be found in that systems based on this design can be used to assist cell identification in a variety of contexts, whereas a practical implication can be found that these systems can be deployed to assist biomedical workflows quickly and at low cost. In conclusion, this system demonstrates the potentials of end-to-end learning systems for faster and more accurate automated cell analysis.